ESSEX HORSE TRIALS INC (EIN 223042941) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1987

Legal Domicile

Principal Officer

MARILYN PAYNE

Phone

8024406181

Tax Period

2024-10-01 to 2025-09-30

ESSEX HORSE TRIALS INC, founded in 1987, is a small nonprofit in the Recreation & Sports sector that reported $132K in total revenue in fiscal year 2024. Revenue fell 38% from the prior year — a significant decline worth monitoring.

Mission

ESSEX HORSE TRIALS MISSION IS TO PROMOTE, EDUCATE, TRAIN, PROVIDE FACILITIES, AND HOLD AN EQUESTRIAN COMPETITION EVENT ANNUALLY. THE PRIMARY BENEFICIARY IS THE GREATER NEWARK LIFE CAMP WHICH IS A RECOGNIZED SECTION 501(C)(3) NONPROFIT ENTITY THAT PROVIDES AN ENRICHING DAY-CAMP EXPERIENCE FOR OVER 300 INNER-CITY YOUTH EACH SUMMER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $131,908

Investment Income $0

Other Revenue $0

TOTAL REVENUE $131,908

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $101,778

Other Expenses $132,178

TOTAL EXPENSES $132,178

Year-over-Year Comparison

	2024	2023	Change
Revenue	$131,908	$211,835	-0.4%
Expenses	$132,178	$194,675	-0.3%
Net Income	$-270	$17,160	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RONALD A KENNEDY	TRUSTEE/VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
GUY J TORSILIERI	TRUSTEE/VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
RALPH E JONES	TRUSTEE/TREASURER	1.00	Officer Director	$0	$0	$0
MARILYN PAYNE	TRUSTEE/PRESIDENT	10.00	Officer Director	$0	$0	$0
MORGAN G ROWSELL	TRUSTEE	10.00	Director	$0	$0	$0
JULIE BERMAN	TRUSTEE	1.00	Director	$0	$0	$0
JAMES C BRADY III	TRUSTEE	1.00	Director	$0	$0	$0
GREGORY STALLER	TRUSTEE	1.00	Director	$0	$0	$0
BRITA TANSEY	TRUSTEE	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$131,908	$132,178	$133,010	$-270
2024	$211,835	$194,675	$133,280	$17,160
2023	$237,970	$254,093	$116,952	$-16,123
2022	$254,210	$272,616	$132,243	$-18,406
2021	$290,747	$267,726	$199,449	$23,021
2019	$521,000	$491,016	$211,667	$29,984
2018	$391,903	$369,953	$161,683	$21,950

ESSEX HORSE TRIALS INC